Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) are two forms of muscular dystrophy that result from mutations in the dystrophin gene. These conditions lead to muscle weakness and degeneration over time. Early detection and diagnosis through prenatal testing can be crucial for families with a history of these conditions. DNA Labs UAE offers a comprehensive DMD/BMD Mutation Screening 26 Exons Prenatal Test, designed to detect mutations in the 26 exons of the dystrophin gene, which are commonly associated with these disorders. This test is priced at 2100 AED, making it accessible for many families seeking peace of mind.
Symptoms of DMD and BMD
Understanding the symptoms of Duchenne and Becker Muscular Dystrophy is crucial for early detection and intervention. Symptoms of DMD usually appear in early childhood and progress rapidly. They include muscle weakness that starts in the legs and pelvis, frequent falls, difficulty getting up or running, and learning disabilities. As the condition progresses, it affects upper body muscles, leading to difficulties in mobility and eventually affecting the heart and respiratory muscles.
BMD symptoms are similar but generally milder and progress more slowly. They can start in late childhood or adolescence, and sometimes even in adulthood. The progression varies significantly among individuals, but it typically involves muscle weakness and wasting, cramps, and occasionally heart problems.
Importance of Prenatal Testing
Prenatal testing for DMD and BMD mutations is vital for families with a history of these conditions. It provides early detection, which is crucial for planning and managing the condition. Knowing in advance allows parents to seek early intervention strategies, including physical therapy, medications, and in some cases, surgery, which can significantly improve the quality of life for the child. Additionally, it offers families the chance to make informed decisions about their pregnancies.
DMD/BMD Mutation Screening 26 Exons Prenatal Test
DNA Labs UAE’s DMD/BMD Mutation Screening 26 Exons Prenatal Test is a comprehensive screening tool designed to detect mutations in the 26 exons of the dystrophin gene. These exons are crucial parts of the gene and are commonly associated with DMD and BMD. The test is conducted on a prenatal sample, providing early detection of potential mutations. Priced at 2100 AED, this test is an accessible option for many families looking to understand their child’s health outlook better.
How the Test Works
The test requires a prenatal sample, which can be obtained through amniocentesis or chorionic villus sampling (CVS). These procedures are generally safe and are performed by a healthcare professional. Once the sample is collected, it is analyzed in the laboratory to detect any mutations in the 26 targeted exons. The results provide valuable information about the risk of the child being affected by DMD or BMD.
Conclusion
DNA Labs UAE’s DMD/BMD Mutation Screening 26 Exons Prenatal Test offers hope and valuable information for families with a history of Duchenne or Becker Muscular Dystrophy. By providing early detection at an accessible price of 2100 AED, it enables families to plan and seek early intervention strategies. For more information or to schedule a test, visit DNA Labs UAE.
